TW0006547003
TW0006547003
MEDIGEN VACCINE BIOLOGICS CORPO
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 20.38B EUR | 14.94B EUR | 18.84B EUR | 12.41B EUR |
Enterprise Value | 19.45B EUR | 15.79B EUR | 19.55B EUR | 12.1B EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | 42.47x | -- | -- | -- |
Price to Sales | 35.52x | 26.04x | 31.2x | 24.93x |
Price to Book | 5.73x | 4.2x | 5.35x | 3.57x |
EV/Revenue | 33.89x | 27.51x | 32.38x | 24.31x |
EV/EBITDA | -336.17x | -- | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -0.88% | -1.46% | -0.94% | -0.14% |